Topotecan and Cisplatin Versus Etoposide and Carboplatin in 1st Line Treatment of Patients With Small Cell Lung Cancer and Extensive Disease (SCLC-ED)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00812266
Recruitment Status : Terminated (Slow accrual)
First Posted : December 22, 2008
Last Update Posted : January 26, 2016
Information provided by (Responsible Party):
Seppo W. Langer, Danish Oncological Lung Cancer Group

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : December 2013
  Actual Study Completion Date : January 2015